Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Hide A Way Dairy
WARNING LETTER
•Hide A Way Dairy•April 15, 2011

Hide A Way Dairy – FDA Warning Letter, Apr 15, 2011

Record Details

The FDA conducted an inspection of Hide A Way Dairy, owned by Mr. Robert J. Vander Dussen, in Portales, New Mexico, from April 11-15, 2011. The inspection revealed significant violations of the Federal Food, Drug, and Cosmetic Act, primarily concerning the offering of adulterated animals for slaughter. A key finding was that a dairy cow consigned on January 24, 2011, contained Sulfadimethoxine residues in its liver (0.311 ppm) and muscle (0.384 ppm), significantly exceeding the FDA tolerance of 0.1 ppm (21 CFR 556.640). This rendered the animal's tissues adulterated under section 402(a)(2)(C)(ii) of the Act. Furthermore, the FDA found that the dairy held animals under inadequate conditions, increasing the likelihood of medicated animals with harmful drug residues entering the food supply, which constitutes adulteration under section 402(a)(4). Specific deficiencies included a failure to maintain an adequate system for ensuring proper drug withdrawal times before slaughter and a failure to maintain and review complete treatment records for medicated animals. The firm's response to the FDA 483 was deemed inadequate due to a lack of documentation for corrective actions. The FDA emphasized the need for prompt corrective action and establishment of preventative procedures, warning of potential regulatory actions like seizure or injunction if compliance is not achieved. The letter also noted previous USDA/FSIS notifications regarding illegal drug residues in animals from the dairy in 2004, 2008, and 2010, highlighting a history of non-compliance. A written response detailing corrective actions is required within fifteen working days.

Company
Hide A Way Dairy
Inspection date
April 15, 2011
Product type
Drugs
Office
Denver District Office
Person
  • Paul J. Teitell (District Director)
View Company Profile

ID · 3b0b9df8-81e6-4b1f-a3c4-45dee9aa8838

Violation Codes4
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 360b21 U.S.C. 342(a)(4)21 CFR 556.640

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hide A Way Dairy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.